Published in JAMA on January 28, 1974
Thrombotic thrombocytopenic purpura: a syndrome of intravascular platelet consumption. Can Med Assoc J (1976) 1.59
Case series: splenectomy: does it still play a role in the management of thrombotic thrombocytopenic purpura? Can J Surg (2010) 0.86
Thrombotic thrombocytopenic purpura treated with plasma exchange or exchange transfusions. West J Med (1991) 0.84
Thrombotic thrombocytopenic purpura (TTP) and splenectomy: a current appraisal. Ann Surg (1978) 0.83
Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood (1968) 2.71
Melphalan in multiple myeloma. Blood (1967) 1.25
The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years. Br J Haematol (1989) 1.21
Fungal infection in acute leukemia. Cancer (1972) 1.17
Intracerebral involvement in Hodgkin's disease: a report of 6 cases and review of the literature. Cancer (1979) 1.14
Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med (1987) 1.06
Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia. Recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR series. J Exp Med (1982) 1.03
Thrombotic thrombocytopenic purpura: a ten-year experience. Blood (1980) 1.02
Observations on cell lines derived from a patient with Hodgkin's disease. Cancer Res (1978) 1.01
High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase. J Exp Med (1987) 1.00
Vincristine-induced bladder atony. Cancer (1971) 0.97
Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse. Cancer (1978) 0.95
Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed. J Clin Invest (1987) 0.91
Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: results of CALGB protocol 7113. Leuk Res (1979) 0.91
Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B. Blood (1984) 0.91
Association of monocytic leukemia in patients with extreme leukocytosis. Am J Med (1980) 0.90
Myeloma proteins, Bence Jones proteins and normal immunoglobulins in multiple myeloma. Blood (1967) 0.89
Tartrate-resistant acid phosphatase staining of monocytes in Gaucher disease. Am J Hematol (1985) 0.89
Pseudomonas maltophilia exoenzyme activity as correlate in pathogenesis of ecthyma gangrenosum. J Clin Microbiol (1986) 0.88
Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study. J Clin Oncol (1988) 0.87
Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: studies of patients with clonal hematopoietic neoplasia. Leuk Res (1984) 0.86
Association of susceptibility to certain hematopoietic malignancies with the presence of Ia allodeterminants distinct from the DR series; utility of monoclonal antibody reagents. Immunol Rev (1983) 0.85
Guillain-Barré syndrome in a patient with Hodgkin's disease. Mt Sinai J Med (1978) 0.85
Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia. Cancer Res (1971) 0.84
Clotrimazole treatment of oral candidiasis in patients with neoplastic disease. Am J Med (1984) 0.83
Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis. Am J Med (1985) 0.83
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience. Cancer (1982) 0.83
Mitoxantrone in acute lymphoblastic leukemia. Cancer Treat Rev (1983) 0.83
Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia. Semin Oncol (1984) 0.82
Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies. Blood (1985) 0.82
The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B. J Clin Oncol (1991) 0.82
Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: only polycythemia vera has endogenous colonies. Leuk Res (1989) 0.82
Macroglobulinemia and steatorrhea: roentgen and pathologic findings in the intestinal tract. Radiol Clin North Am (1969) 0.82
TdT-positive acute leukemia with monocytoid characteristics: clinical, cytochemical, cytogenetic, and immunologic findings. Blood (1984) 0.82
Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusion. Cancer (1978) 0.81
Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia. Med Pediatr Oncol (1983) 0.80
Protein C and S levels in acute leukemia. Am J Hematol (1991) 0.79
Intermittent melphalan therapy in multiple myeloma. JAMA (1969) 0.79
Daunorubicin in the therapy of acute granulocytic leukemia. Cancer Res (1973) 0.79
A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia. Med Pediatr Oncol (1979) 0.78
Central nervous system involvement at presentation in acute granulocytic leukemia. A prospective cytocentrifuge study. Am J Med (1980) 0.77
Improved survival of increased-risk myeloma patients on combined triple-alkylating-agent therapy: a study of the CALGB. Blood (1979) 0.77
Management of leukaemia-associated disseminated intravascular coagulation (DIC). Haematologia (Budap) (1982) 0.77
Treatment of adult leukemia with L-asparaginase (NSC-109229). Cancer Chemother Rep (1971) 0.77
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group B. Cancer (1980) 0.76
Clotrimazole treatment for prevention of oral candidiasis in patients with acute leukemia undergoing chemotherapy. Results of a double-blind study. Am J Med (1986) 0.76
Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen. Leukemia (1988) 0.76
Therapy of refractory adult acute lymphoblastic leukemia with vincristine and prednisone plus tandem methotrexate and L-asparaginase. Results of a Cancer and Leukemia Group B Study. Am J Clin Oncol (1986) 0.76
Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia. Cancer (1975) 0.76
Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope. J Clin Invest (1985) 0.75
Chronic thrombotic thrombocytopenic purpura: report of a case with five relapses and review of the literature. Mt Sinai J Med (1978) 0.75
Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemia. Leukemia (1987) 0.75
Procarbazine, vinblastine, and actinomycin D in stage III and IV melanoma with or without methanol-extracted residue of Bacillus Calmette-Guérin. Cancer Treat Rep (1979) 0.75
Chemoimmunotherapy in acute myelocytic leukemia. Isr J Med Sci (1977) 0.75
Uric acid nephropathy after radiation therapy in a patient with chronic lymphocytic leukemia. Am J Hematol (1992) 0.75
Polycythaemia vera associated with raised concentrations of haemoglobin F. Lancet (1977) 0.75
Daunorubicin (NSC-83142) versus daunorubicin plus prednisone (NSC-10023) versus daunorubicin plus vincristine (NSC-67574) plus prednisone in advanced childhood acute lymphocytic leukemia. Cancer Chemother Rep (1972) 0.75
Definition of AML susceptibility and classification using monoclonal antibodies. Med Oncol Tumor Pharmacother (1984) 0.75
Central nervous system involvement at presentation in the chronic phase of chronic myelogenous leukemia in childhood. Cancer (1978) 0.75
Confirming evidence for the clonal development and stem cell origin of Philadelphia chromosome-negative chronic myelogenous leukemia. Am J Hematol (1984) 0.75
Evaluation of tryptophan mustard (NSC-62403) in patients with plasmacytic myeloma. Cancer Res (1967) 0.75
Panel 3: phase III investigations. Clin Pharmacol Ther (1975) 0.75
Waldenström's macroglobulinemia. Cancer Invest (1991) 0.75
The reproducibility of acute lymphoblastic leukemia phenotype determinations: evaluation of monoclonal antibody and conventional hematopoietic markers. Leuk Res (1986) 0.75
Iatrogenic and idiopathic acute myelogenous leukemia: a comparison of clinical features and treatment complications. Med Oncol Tumor Pharmacother (1987) 0.75
Increased incidence of acute promyelocytic leukemia in patients with ulcerative colitis. Ann Intern Med (1982) 0.75
Therapeutic strategies in acute myelocytic leukemia: a status report of the experience of CALGB. Cancer and Leukemia Group B. Haematol Blood Transfus (1987) 0.75
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study. Cancer (1981) 0.75
Therapeutic leukapheresis in a patient with hairy cell leukemia presenting with a white cell count greater than 500,000 /microliter. Transfusion (1982) 0.75
Sequential intermediate-dose cytosine arabinoside and mitoxantrone for patients with relapsed and refractory acute myelocytic leukemia. Am J Hematol (1990) 0.75
Therapy for chronic myelogenous leukemia in blast crisis with etoposide and 5-azacitidine administered by continuous infusion: a Cancer and Leukemia group B Study. Cancer Treat Rep (1985) 0.75
MER immunotherapy and combination chemotherapy for advanced, recurrent Hodgkin's disease. Cancer and Leukemia Group B study. Cancer Clin Trials (1981) 0.75
TdT-positive acute leukemia with monocytoid characteristics. Clinical, cytochemical, cytogenetic and immunologic findings. 24 patients. Haematologica (1988) 0.75
Acute myelocytic leukemia. Arch Intern Med (1976) 0.75
Acid output and ulcers. Lancet (1977) 0.75
Systemic Weber-Christian disease and thrombocythemia terminating in reticulum-cell sarcoma. Am J Clin Pathol (1974) 0.75
Human immunodeficiency virus infection in transfused patients with acute leukemia. Mt Sinai J Med (1989) 0.75
Therapeutic leukopheresis of acute myelo-monocytic leukemia in pregnancy. Med Pediatr Oncol (1978) 0.75
Mitoxantrone in patients with acute leukemia in relapse. Cancer Res (1983) 0.75
Tryptophan mustard (NSC-62403) in the treatment of acute leukemia and malignant solid tumors in children. Cancer Chemother Rep (1968) 0.75
Trisomy 22--a new abnormality found in acute leukemia characterized by eosinophilia and monocytoid blasts expressing immature differentiation antigens. Cancer Genet Cytogenet (1986) 0.75
The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma. Med Pediatr Oncol (1975) 0.75
Combination chemotherapy for non-Hodgkin lymphomas: a ten year follow-up study. Med Pediatr Oncol (1979) 0.75
P185BCR-ABL in two patients with late appearing Philadelphia chromosome-positive acute nonlymphocytic leukemia. Leukemia (1989) 0.75
Sequential mitoxantrone, daunorubicin, and cytosine arabinoside for patients with newly diagnosed acute myelocytic leukemia. Am J Hematol (1997) 0.75
Recent advances in hematology as related to diseases of the colon and rectum. Surg Clin North Am (1972) 0.75
Failure of hydroxyurea (NSC-32065) and prednisone (NSC-10023) in the treatment of acute myelocytic leukemia. Cancer Chemother Rep (1971) 0.75
Pretreatment marrow cytogenetic status: a predictor of response to remission induction therapy in acute myelogenous leukemia. Mt Sinai J Med (1983) 0.75